Itraconazole Sandoz (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. Inhibiting ergosterol synthesis compromises membrane integrity, leading to inhibited growth and death of the fungus.

The specific dose and treatment duration are determined by the prescribing clinician based on the infection type, severity, patient weight, and renal or hepatic function. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for itraconazole in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other azole antifungals, itraconazole offers a broad spectrum against many systemic fungi and has good tissue penetration. However, it has a higher potential for drug‑drug interactions due to CYP3A4 inhibition, which may be less pronounced with newer agents such as voriconazole or posaconazole.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Itraconazole Sandoz is taken orally, usually with food or a full glass of water to enhance absorption. The exact administration instructions, including whether to swallow whole or dissolve, depend on the specific dosage form supplied by the manufacturer.

Serious risks include hepatotoxicity, which may present as jaundice or elevated liver enzymes, and congestive heart failure due to fluid retention. Patients should be monitored for signs of liver dysfunction or worsening cardiac symptoms throughout therapy.

Individuals with known hypersensitivity to itraconazole or any azole antifungal should avoid the product. It is also contraindicated in patients with uncontrolled congestive heart failure and should be used with caution in those with significant liver impairment.